BioFront Technologies Achieves Quality Management ISO 9001:2015 Certification
By achieving the International Organization for Standardization ISO 9001:2015, BioFront Technologies has demonstrated its ability to consistently provide food allergen test kits and related products and services that meet customer and applicable statutory and regulatory requirements. In addition, BioFront aims to enhance customer satisfaction through the effective application of its quality management system, including processes for improvement of the system and the assurance of conformity to customer and applicable domestic and global statutory and regulatory requirements.
Jason Robotham Ph. D, president of BioFront Technologies, said: "the latest revision of ISO 9001:2015 raises the bar by meeting FSSC 22000-Q requirements, and adds new elements for process based approach to quality and safety thus ensuring the highest quality standards and confidence in food safety and analytical performance for our customers."
BioFront Technologies produces diagnostic kits and related products aimed at the detection of food allergens and infectious diseases. Founded in 2010, BioFront has pioneered the universal use of monoclonal antibodies as the basis for detecting and quantifying trace amounts of contaminating allergenic proteins in food products and on surfaces. The monoclonal antibodies used in their extensive line of MonoTrace kits significantly improve lot' to' lot consistency, reduce cross-reactivity, and minimize food matrix interference. The current MonoTrace platform includes ELISA kits that detect milk, egg, gluten, legumes (peanut, soy and lupin), crustacea, seeds (buckwheat, mustard, and sesame), and tree nuts (almond, Brazil nut, cashew, coconut, hazelnut, macadamia, pecan, pine nut, pistachio and walnut).